Nabilone & Marijuana Addiction

Phase 2

Completed

• Conditions: Marijuana Smoking
• Interventions: Drug: Cesemat

• Registration Number: NCT01025700
• Lead Sponsor: University of British Columbia

Brief Summary

Safety of Nabilone in reducing marijuana craving

Detailed Description

Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2009-12-02
• Study First Submitted QC: 2009-12-02
• Study First Posted: 2009-12-03
• Primary Completion: 2010-06
• Study Completion: 2010-10
• Status Verified: 2011-02
• Last Update Submitted: 2011-02-16
• Last Update Posted: 2011-02-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• 19 years or older
• History of marijuana use

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Cesemat	Cesemat	-

Primary Outcome Measures

Name	Time	Method
Safety and tolerability to Nabilone

Secondary Outcome Measures

Name	Time	Method
Marijuana craving questionnaire

Trial Locations

Locations (1)

Vancouver General Hospital - Psychiatry Outpatient; 🇨🇦 Vancouver, British Columbia, Canada